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I N T R O D U C T I O N
The resting conductance of the sarcolemma of skeletal 
muscles consists of a Cl
 component largely contrib-
uted by the CLC-1 Cl
 channel (Jentsch et al., 2002, 
2005; Chen, 2005). It has been shown that the inhibi-
tion of the sarcolemmal Cl
 conductance is critical for 
reducing the shunting conductance and, therefore, for 
helping the muscle overcome fatigue resulting from the 
accumulation of extracellular K
+ ions after continuous 
firing of action potentials (Pedersen et al., 2004, 2005). 
This antifatigue mechanism is thought to result from 
the ATP inhibition of the common gating of CLC-1 in 
the presence of an acidic intracellular pH (Bennetts 
et al., 2007; Tseng et al., 2007). Presumably, ATP acts on 
the protonated CLC-1 channel by binding to the cystathio-
nine -synthase (CBS) domain located at the C-terminal 
cytoplasmic region (Meyer and Dutzler, 2006; Markovic 
and Dutzler, 2007; Meyer et al., 2007), although the mo-
lecular mechanism of the CLC-1 modulation by ATP ap-
pears to be unsettled. Although our study (Tseng et al., 
2007) and that of Bennetts et al. (2005, 2007) demon-
strated  an  ATP  inhibition  of  the  common  gating  of 
CLC-1, others have suggested that ATP may exert its   
actions on CLC-1 indirectly via an accessory protein   
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(Zifarelli and Pusch, 2008). We have recently shown that 
the controversy may result from different degrees of 
oxidation of the CLC-1 channel molecule in various 
experimental conditions (Zhang et al., 2008). However, a 
study to provide evidence for a direct binding of ATP to 
the predictive ATP-binding site of CLC-1 is imperative.
So far, the high resolution structure of the C-terminal 
domain of CLC-1 is not available. However, the C-terminal 
structure is known in several CLC molecules, including 
CLC-0, CLC-Ka, CLC-5, and CmCLC (Meyer and Dutzler, 
2006; Markovic and Dutzler, 2007; Meyer et al., 2007; 
Feng et al., 2010). All these C-terminal structures show 
conserved CBS domains. The CLC-5’s C-terminal struc-
ture is particularly helpful because it is the only CLC 
structure in which the ATP molecule can be seen at the 
ATP-binding  site  in  the  CBS  domain.  Mutating  two 
CLC5’s  amino  acid  residues  that  interact  with  the 
bound ATP, as guided by the x-ray structure, reduces 
the ATP binding affinity (Meyer et al., 2007). Based on the 
C-terminal domain of CLC-5, we constructed a homol-
ogy model of the C terminus of CLC-1. We mutated several 
previously unexamined amino acid residues in CLC-1 
that appear to interact with the bound ATP molecule.   
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The common gating of CLC-1 has been shown to be inhibited by intracellular adenosine triphosphate (ATP) in 
acidic pH conditions. Such modulation is thought to be mediated by direct binding of ATP to the cystathionine 
-synthase (CBS) domains at the C-terminal cytoplasmic region of CLC-1. Guided by the crystal structure of the 
C-terminal domain of CLC-5, we constructed a homology model of CLC-1’s C terminus and mutated critical amino 
acid residues lining the potential ATP-binding site. The CLC-1 mutations V634A and E865A completely abolished 
the ATP inhibition of CLC-1, consistent with the loss of ATP binding seen with the corresponding mutations in CLC-5. 
Mutating two other residues, V613 and V860, also disrupted the ATP modulation of CLC-1. However, placing aro-
matic amino acids at position 634 increases the apparent ATP affinity. Mutant cycle analyses showed that the modu-
lation effects of ATP and cytidine triphosphate on wild-type CLC-1 and the V634F mutant were nonadditive, 
suggesting that the side chain of amino acid at position 634 interacts with the base moiety of the nucleotide. The 
mutation effects of V634F and V613A on the ATP modulation were also nonadditive, which is consistent with the as-
sertion suggested from the homology model that these two residues may both interact with the bound nucleotide. 
These results provide evidence for a direct ATP binding for modulating the function of CLC-1 and suggest an overall 
conserved architecture of the ATP-binding sites in CLC-1 and CLC-5. This study also demonstrates that CLC-1 is a 
convenient experimental model for studying the interaction of nucleotides/nucleosides with the CBS domain.
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y358 ATP binding to the CLC-1 channel
Mutagenesis and channel expression
The ATP modulation of CLC-1 is controlled by oxidation and re-
duction (Zhang et al., 2008). We therefore chose Xenopus laevis 
oocytes  as  the  channel  expression  system,  and  relatively  large 
electrodes (with a tip diameter of 7–10 µm) were used to excise 
large membrane patches because the ATP effect had previously 
been shown to be more stable using these experimental approaches 
compared with those using small patches excised from mamma-
lian cells (Zhang et al., 2008). To further avoid decline of the cur-
rent  as  a  result  of  potential  oxidation,  all  electrophysiological 
experiments were conducted in bath solutions containing 50–100 µM 
of reducing reagents (dithiothreitol or -mercaptoethanol).
All mutants and the WT human CLC-1 Cl
 channel were con-
structed in the pTLN vector. Messenger RNAs were synthesized 
using the SP6 mMessage mMachine kit (Invitrogen). Harvesting 
Xenopus oocytes and the injection of messenger RNAs followed 
routine procedures as described previously (Chen, 1998; Li et al., 
2005). Excised inside-out patch recordings were performed 3–5 d 
after RNA injections. The point mutants were constructed using 
the QuickChange II Site-Directed Mutagenesis kit (Agilent Tech-
nologies).  The  mutated  region  was  confirmed  by  commercial 
DNA sequencing services.
Electrophysiological recordings
Electrophysiological experiments were conducted using the Axo-
patch 200B amplifier and the Digidata 1320 A/D board controlled 
by  pClamp8  software  (Axon  Instruments/Molecular  Devices). 
Signal  digitization  and  filtering  (by  the  digital  filter  in  the 
pClamp8 program) were 10 kHz and 5 kHz, respectively. The tip 
diameter  of  the  recording  electrodes  was  relatively  large,  and 
these electrodes normally had a resistance of 0.4–0.6 M when 
filled with a pipette (extracellular) solution containing 120 mM 
N-methyl-d-glucamine–Cl, 1 mM MgCl2, 10 mM HEPES, and 1 mM 
EGTA, pH 7.4. Because the ATP effect was not prominent at a 
neutral pHi, we examined the effect of ATP at pHi 6.8. The bath 
(intracellular) solutions had the same ionic components, with 
pHi being adjusted to 6.8 after the desired concentrations of ATP 
were added. Mg
2+-ATP was purchased from Sigma-Aldrich. A stock 
solution of 100 mM was made in distilled water and was stored at 
20°C. Working solutions of ATP were made on the same day of 
the experiments.
For any given patch, the membrane potential of the excised 
patch was held at 0 mV. The voltage protocol used to construct 
The results show that mutating these residues greatly   
alters the effect of ATP on CLC-1. We have also con-
structed double mutants and have studied the effects of 
ATP and CTP or ATP and GTP on the wild-type (WT) 
and mutant channels. The results from ATP and CTP or 
ATP and GTP modulations of these channels suggest 
that the residue at position 634 very likely interacts 
directly with the base moiety of the nucleotide. Further-
more, individual mutations also show nonadditive effects 
on the ATP modulation of CLC-1, a sign for an energy 
coupling between these residues in interacting with the 
bound ATP molecule.
M AT E R I A L S   A N D   M E T H O D S
Construction of the homology model of the C-terminal 
cytoplasmic domain of CLC-1
The sequence of human CLC-1 (Steinmeyer et al., 1991) from 
L598 to T874 was used to construct the homology model, corre-
sponding to the sequence of CLC-5 from H578 to N737. Two 
segments in the CLC-1 C terminus, one from L598 to R672 (cor-
responding to H578 to I641 in CLC-5) and the other from P825 
to T874 (corresponding to P687 to A736 of CLC-5), contain the 
sequence for the CBS1 and CBS2, respectively. However, the seg-
ment from residue 671 to residue 824 of CLC-1 is missing in 
CLC-5. It is unknown whether this segment is disordered (i.e., 
intrinsically unstructured) or not. Excluding this missing segment, 
the sequence alignment using Vector NTI software (Invitrogen) 
showed a sequence identity of 19.7% and a similarity of 31.3% be-
tween  CLC-1  and  CLC-5.  Homology  modeling  was  performed 
with  a  bound  ATP  molecule  using  the  MODELLER  program 
(Martí-Renom et al., 2000). The structures of the two segments 
containing the sequence of CBS domains of CLC-1 (Fig. 1, red 
and yellow) were determined using the crystal structure of CLC-5 
as a template (Protein Data Bank accession no. 2J9L) with energy 
minimization using the MODELLER program. It can be seen that 
the missing segment between the two CBS domains (Fig. 1, dotted 
line)  is  remote  from  the  bound  ATP  and  thereby  has  little   
effect on the structures of the two CBS domains forming the ATP-
binding site (Fig. 1).
Figure  1.  Homology  modeling  of  the  C-terminal 
domain of CLC-1. (A) Homology model of the CBS 
domain of CLC-1 shown in ribbon presentation. The 
two segments of CLC-1 sequence corresponding to 
CLC-5 are colored in red and yellow, whereas the 
segment that is missing in CLC-5 is illustrated with a 
dotted black line. ATP is shown in stick presentation 
(in CPK color). Key amino acids examined in this 
study are colored in yellow (V613), orange (V634), 
blue (V860), and purple (E865). (B) Sequence align-
ment of CLC-0, CLC-1, CLC-5, and AtCLC-a for the 
region encompassing the four residues shown in A.  Tseng et al. 359
were normalized to the Po
c in the absence of ATP. The normalized 
values were then plotted against ATP concentrations (see Figs. 6 
and 7) and were fit into Eq. 2 (Zifarelli and Pusch, 2009):
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For mutant cycle analyses, the interaction between the ligand 
and the binding site can be altered by the perturbation on the   
ligand, the binding site, or both. The free energy of the interac-
tion, which is determined from Ko or Kc (Go = RTlnKo and Gc = 
RTlnKc), can therefore be perturbed by manipulating the ligand 
and the receptor individually or simultaneously, thus forming a 
mutant cycle as shown in Fig. 6. If the two parts changed are inde-
pendent of each other, the free energy perturbation caused by 
the double manipulation is equal to the sum of the free energy 
perturbations from individual manipulations. Namely,
  ∆ ∆
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where G(X,Y) is the free energy of binding of the ligand Y to the 
channel X. A rearrangement of Eq. 3 leads to
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where K(X,Y) is Ko or Kc from the experiment in channel X using 
ligand Y. The coupling coefficient, Ω, for the two perturbations in 
this mutant cycle is defined as
  Ω = ( ) × ( )     ( ) × ( )     K X Y    K X Y K X Y    K X Y . 1 1 2 2 1 2 2 1 , , / , ,   (4)
When Ω is close to unity, there is little coupling energy between 
these two manipulations because the coupling energy of the pair 
of manipulations is given by RTlnΩ ≈ 0. On the other hand, when 
Ω is significantly different from 1, the mutant cycle analysis sug-
gests that the two manipulations are not independent. Previous 
studies have used mutant cycle analyses to identify the interacting 
residues located in the potassium channel pore and on the pore-
blocking toxin, respectively (Hidalgo and MacKinnon, 1995; 
Naranjo and Miller, 1996; Ranganathan et al., 1996).
The  mutant  cycle  approach  can  be  modified  for  examining 
whether the free energy perturbations of two mutations within the 
binding site of ATP are additive. Examples are shown in Fig. 7. 
Again, an Ω value significantly deviating from unity suggests that 
these two mutations may be coupled energetically, and thus the 
two residues may interact with the bound ligand simultaneously.
Online supplemental material
Fig. S1 shows a comparison of the two homology models of CLC-1’s 
C-terminal domain based on the high resolution structures of CLC-5 
and CmCLC. Fig. S2 shows the values of Ω calculated from the Po
c 
values at other voltages. Online supplemental material is available at 
http://www.jgp.org/cgi/content/full/jgp.201010495/DC1.
R E S U LT S
The  C-terminal  cytoplasmic  regions  of  all  eukaryote 
CLC molecules contain two tandem CBS domains that 
form  a  putative  ATP-binding  site  (Scott  et  al.,  2004; 
the voltage dependence of the common gate open probability 
(Po
c-V curve) has been described previously (Tseng et al., 2007; 
Zhang et al., 2008). This voltage protocol starts with a test voltage 
varying from 120 to 140 mV (in 20-mV steps) for 400 ms fol-
lowed by a brief depolarizing voltage to 170 mV for 400 µs and 
then finally a tail voltage at 100 mV for 300 ms. Channel cur-
rents were recorded in a given patch both in the absence and in 
the presence of ATP. The current in response to the tail voltage 
was fitted to a double-exponential function, and the initial value 
of  the  tail  current  was  determined  by  extrapolating  the  fitted 
curve to the start of the tail voltage. The initial tail current of each 
trace was then normalized to the initial tail current obtained after 
the 120-mV test voltage in the absence of ATP. Because the fast 
gate open probability is fully activated by the brief voltage step at 
170 mV, the normalized initial tail current represents the open 
probability of the common gate (Po
c) at the preceding test voltage 
(Accardi and Pusch, 2000; Duffield et al., 2003; Bennetts et al., 
2005). The initial tail current in the presence of ATP was also nor-
malized to the maximal tail current (with 120-mV test voltage) in 
the absence of ATP. The normalized value (or Po
c) was then plot-
ted against the test voltage, V. The half-activating voltage (V1/2) of 
the Po
c-V curve was determined by fitting the data points to a 
Boltzmann equation:
  P P P o
c
min min 1 2   1 1   exp zF V V RT . = + − + − ( )     { } ( )/ / /  
The difference in V1/2 (i.e., V1/2) between the absence and pres-
ence of ATP was then determined as the qualitative response to a 
certain concentration of ATP.
Mutant cycle analyses
Data analyses and presentations were performed using the combi-
nation of pClamp8 and Origin software (Origin Laboratory). One 
way of evaluating the apparent affinity of ATP was to construct the 
dose-dependent curve by plotting V1/2 as a function of the ATP 
concentration. The apparent K1/2 value was then determined ac-
cording to the Michaelis-Menten equation
  ∆ ∆ V V 1   K ATP , 1 2 1 2 max 1 2 / / , / / / = + [ ] ( )    (1)
where V1/2,max is the maximal shift of the V1/2 at saturated ATP 
concentrations, whereas K1/2 is the apparent half-effective concen-
tration in shifting the Po
c-V curve. We used the aforementioned 
analysis for a qualitative comparison of the ATP effects. However, 
the apparent K1/2 derived from the shift of V1/2 does not truly re-
flect the half-point of ligand occupancy. To estimate the half-point 
of occupancy (or binding probability) of ATP, we used a four-state 
allosteric model to describe the opening and closing of the chan-
nel with or without ATP binding (Zifarelli and Pusch, 2009):
   
(SCHEME 1)
In Scheme I, C and O represent the closed and open states of the 
common gate, and a and c represent the gating equilibrium con-
stants of the ATP-unbound and the ATP-bound channels. Kc and 
Ko are the binding dissociation constants of the closed-state and 
open-state channels for ATP, respectively. To determine Ko and Kc, 
the values of Po
c at various ATP concentrations, namely Po
c(ATP), 360 ATP binding to the CLC-1 channel
on the recently solved structure of CmCLC (Fig. S1 A). 
The  homology  model  based  on  the  CLC-5  structure 
suggested several residues that might interact with the 
bound ATP molecule, including V613, V634, V860, and 
E865. Other nearby residues, such as T636, P638, H847, 
and L848, appear to line the ATP-binding pocket as 
well. However, because the latter four residues in CLC-1 
have been examined previously (see Fig. S1 B for the 
residues  in  CLC-1  whose  mutations  affect  the  ATP   
effect), we focused on the former four residues in this 
study. Fig. 1 B shows the alignment of the amino acid 
sequence from CLC-0, CLC-1, CLC-5, and AtCLC-a in 
Wellhauser et al., 2006). This predicted ATP-binding 
site has been directly observed in the high resolution 
structure of the C terminus of CLC-5 (Meyer et al., 2007). 
So far, functional consequences of ATP modulation 
have been shown in CLC-1 as well as in CLC-2, CLC-5, 
and AtCLC-a (Niemeyer et al., 2004; De Angeli et al., 2009; 
Zifarelli and Pusch, 2009). In this study, we use CLC-1 to 
study the interaction of ATP with CBS domains.
We first constructed a homology model of CLC-1’s   
C-terminal region based on the high resolution, ATP-
bound  structure  of  the  C-terminal  domain  of  CLC-5 
(Fig. 1 A). An independent model was built later based 
Figure 2.  Effects of alanine mutations for 
four residues on the ATP modulation of 
CLC-1. (left and middle) Recording traces 
of WT CLC-1 and the four mutants. The 
recordings  in  the  absence  (left)  and  in 
the presence (middle) of 3 mM ATP were 
obtained from the same patch (pHi 6.8). 
(right)  Steady-state  Po
c-V  curves  of  WT 
CLC-1 and the four alanine mutants shown 
in left and middle panels. Black squares, 
red circles, and green triangles represent 
the data in control (before ATP), 3 mM 
ATP, and washout, respectively.  Tseng et al. 361
in CLC-5 were examined previously by others (Meyer   
et al., 2007; Zifarelli and Pusch, 2009). The ATP bind-
ing was shown to be eliminated by the Y617A and D727A 
mutations of CLC-5 (corresponding to V634A and E865A 
of CLC-1). Mutating two equivalent residues, H620 
and D753 (corresponding to V634 and E865 of CLC-1), 
also diminished the ATP inhibitory effect in AtCLC-a 
(De Angeli et al., 2009). In addition, T596 and I722 of 
CLC-5 (corresponding to V613 and V860 of CLC-1) 
have also been suggested to be involved in ATP binding 
to CLC-5 (Meyer et al., 2007). Thus, V613, V634, V860, 
and E865 of CLC-1 are likely to interact with the bound 
ATP molecule.
We started our experiments by examining the ATP 
modulation effects on the mutants in which the WT res-
idues at these four positions were replaced by alanine. 
Fig. 2 shows the effects of ATP on WT CLC-1 and those 
of the four alanine mutants at pHi 6.8. The recording 
traces  were  elicited  by  the  voltage  protocol  used  for 
constructing the common gate Po
c-V curve (see Materi-
als  and  methods).  The  comparison  of  the  recording 
traces both in the absence (Fig. 2, left) and in the pres-
ence of 3 mM ATP (Fig. 2, middle) shows a robust inhi-
bition of WT CLC-1 by ATP (Fig. 2, top), but the effect 
of ATP on these alanine mutants is either weak or com-
pletely lost. The Po
c-V curves shown in Fig. 2 (right) 
indicate that the V634A, V860A, or E865A mutation 
eliminates the ATP modulation effect and the V613 
mutation significantly reduces the ATP effect.
As an initial effort to explore the interaction of ATP 
with the potential binding site more systemically, we re-
placed the WT residues with multiple amino acids at 
regions  containing  the  target  residues.  Among  these 
four CLC molecules, functional ATP modulation effects 
have been observed in the latter three CLCs: ATP inhib-
its the activity of CLC-1 and AtCLC-a, whereas it po-
tentiates the activity of CLC-5. The homology model 
suggested that the adenine ring of ATP appears to be 
surrounded by the side chains of V634, V860, and V613, 
whereas E865 may interact with the ribose of ATP. 
Among these four positions, two corresponding residues 
TA B L e   I
V1/2 and Pmin of the Po
c-V curves of various mutants
Channels/mutants V1/2 Pmin n
WT CLC-1 45.9 ± 2.8
a 0.35 ± 0.02
a 15
V634A 59.3 ± 0.8 0.64 ± 0.02 7
V634D 34.0 ± 3.9 0.28 ± 0.02 7
V634F 56.8 ± 2.0 0.40 ± 0.01 9
V634Y 72.4 ± 1.8 0.50 ± 0.02 7
V634C 44.4 ± 2.5 0.30 ± 0.01 7
V634S 58.3 ± 0.9 0.42 ± 0.02 4
V634G 47.6 ± 2.8 0.32 ± 0.01 7
V634W 54.7 ± 2.6 0.45 ± 0.02 4
E865A 68.5 ± 2.6 0.52 ± 0.01 4
E865D 36.2 ± 2.5 0.24 ± 0.01 11
E865S 43.7 ± 8.2 0.32 ± 0.01 3
V860A 74.6 ± 1.3 0.67 ± 0.02 3
V860S 54.9 ± 7.6 0.26 ± 0.02 4
V860Y 37.5 ± 8.1 0.28 ± 0.01 4
V613A 49.1 ± 3.4 0.37 ± 0.01 7
V613F 43.9 ± 8.7 0.28 ± 0.02 3
V613G 88.2 ± 4.7 0.15 ± 0.01 5
aError from curve fitting.
Figure 3.  Changes of the V1/2 of the 
Po
c-V curves of various mutants in re-
sponse to 3 mM ATP at pHi 6.8. The 
Po
c-V curves of each mutant in the ab-
sence  and  in  the  presence  of  3  mM 
ATP were constructed from the same 
patch, and the V1/2 of the Po
c-V curves 
were obtained by fitting the data points 
to  a  Boltzmann  equation.  The  differ-
ence in V1/2 between control and 3 mM 
ATP (V1/2) was first determined from 
each patch and then averaged (n = 14 
for WT CLC-1 and n = 4–7 for various 
mutants). The label n.c. indicates that 
the  mutant  did  not  show  functional 
current in at least two runs of expres-
sion in Xenopus oocytes. Error bars rep-
resent SEM.362 ATP binding to the CLC-1 channel
half-activation voltage (V1/2) of the common gate Po
c-V 
curve of these functional mutants. We then tested the 
shift of the Po
c-V curve in the functional mutants by   
3 mM ATP at pHi 6.8. Fig. 3 shows the change of the V1/2 
(V1/2) of the Po
c-V curve in response to 3 mM of intra-
cellular ATP (pHi 6.8). For mutations at positions V613, 
V860, and E865, all functional mutants show a sub-
stantial reduction of V1/2 in response to 3 mM ATP.   
However, the effects of mutations at the V634 position 
are diverse. The V634A, V634D, V634G, and V634S muta-
tions suppress the ATP effects, whereas the ATP modu-
lation of V634C is similar to that of the WT channel. 
Interestingly, some mutants, for example V634F, show a 
higher sensitivity to the ATP modulation. Although the 
V1/2 of V634F generated by 3 mM ATP appears to be 
similar to that of WT CLC-1 (Fig. 3), the apparent affin-
ity of ATP in shifting the Po
c-V curve of this mutant is 
higher than that of WT CLC-1—the shift nearly reached 
a maximum at a concentration of 0.1 mM (Fig. 4).
To examine the diverse functional consequences of mu-
tating residue V634, we studied the ATP dose-dependent 
effect in various V634 mutants. Fig. 5 A shows the dose–
response curves of those mutants with less ATP sensitiv-
ity, whereas Fig. 5 B depicts the results of mutants with a 
higher ATP sensitivity. The K1/2 and the maximal value 
of the V1/2 shift (V1/2, max) are shown in Table II. The 
ATP  modulations  of  V634C  and  V634S  mutants  are 
roughly similar to that of the WT channel: the V1/2, max 
in  both  cases  is  similar  to  that  of  the  WT  channel, 
whereas the apparent affinity is only slightly reduced in 
the V634S mutant. However, the V634D and V634G mu-
tants show a more severe disruption in ATP regulation: 
the apparent ATP affinity and/or the maximal shift of 
the V1/2 is reduced in these two mutants. Finally, the 
V634A mutation completely eliminates the ATP modu-
lation effect; even at an ATP concentration of 10 mM, 
no significant shift of V1/2 is observed. However, placing 
these four positions. Mutating V613, V860, and E865   
affects the functional expression; at each site, four out 
of seven mutants did not generate functional current in 
Xenopus oocytes. However, mutations at the V634 posi-
tion are more tolerable; all mutants made in this study 
at this position showed functional current. Table I sum-
marizes the minimal open probability (Pmin) and the 
Figure 4.  The V634F mutation increases the 
apparent  affinity  for  the  ATP  modulation. 
Representative  recording  traces  were  ob-
tained from an excised patch of the oocyte ex-
pressing the V634F mutant in control (0 ATP) 
and in various concentrations of ATP as indi-
cated. The averaged Po
c-V curves of the V634F 
mutant  in  various  ATP  concentrations  are 
shown in the bottom right panel. Error bars 
represent SEM. n = 7.
Figure 5.  Shift of the V1/2 of the Po
c-V curve (V1/2) in various 
mutants of V634 as a function of the ATP concentration. Data 
points were fitted to Eq. 1 to determine the apparent K1/2 and 
V1/2,max. (A) Mutants of V634 in which the apparent ATP affinity 
is reduced. For comparison, the ATP dose–response curve of WT 
CLC-1 is also shown. (B) ATP dose-dependent curves of WT CLC-1, 
V634F, V634Y, and V634W. Error bars represent SEM. n = 4–8.  Tseng et al. 363
(Scheme I) to evaluate the affinities of WT CLC-1 and 
V634F mutants for ATP and other nucleotides. Fig. 6 
gives an example of mutant cycle analysis in which the 
normalized Po
c at 40 mV in different conditions are 
plotted against ligand concentrations. Fig. 6 A shows 
that the free energy changes caused by individual per-
turbations are not additive, with large Ω values (see 
Materials and methods) of 60 and 113 calculated from the 
values of Kc and Ko, respectively. We have also performed 
similar analysis for WT CLC-1 and V634F using ATP and 
GTP as ligands (Table III), with a calculated Ω of 7.6–10. 
However, when deoxy-ATP (dATP) was used to examine 
the interaction of the base with the side chain of resi-
due 634, Ω values close to 1 were obtained (Fig. 6 B 
and Table III). Analyses of Po
c at various voltages re-
vealed similar Ω values in the voltage range between 
140 and 40 mV (Fig. S2 A). These results again are 
consistent with the idea that the base of the bound nu-
cleotide directly interacts with the side chain of residue 
634 of CLC-1.
The  homology  model  of  CLC-1  also  suggests  that 
V613, V860, and E865 may interact with ATP. We thus 
examined the perturbations of the binding free energy 
of ATP to see whether these changes induced by indi-
vidual mutations are additive. Unfortunately, construc-
tion of the ATP dose-dependent curve for V860 mutants 
is difficult because of the very small shift of the Po-V 
curve caused by ATP. We therefore focused on V613 
and E865 and studied the synergistic effects between 
V634F and V613A and between V634F and E865D mu-
tations because these mutations still retain some degree 
of ATP inhibition and at the same time alter the appar-
ent ATP affinity. The concentration-dependent curves 
of the ATP-induced change of Po
c for the single and 
double mutants were constructed, and the ATP affinity 
(Ko and Kc of Scheme I) for each mutant was compared 
with that of WT CLC-1. Fig. 7 A shows a double mutant 
cycle analysis that examines the interaction of the V634F 
and V613A mutations, whereas Fig. 7 B shows the analy-
sis  of  the  interaction  between  V634F  and  E865D.   
aromatic  amino  acids  at  position  634  appears  to  en-
hance the ATP modulation. The apparent K1/2 of the 
ATP effects are 0.026, 0.050, and 0.11 mM for V634F, 
V634Y, and V634W (Table II), corresponding to an in-
crease of the apparent ATP affinity by 30-, 16-, and 
7-fold, respectively.
Because  only  those  mutants  with  an  aromatic  side 
chain at the V634 position showed a high ATP sensitivity 
(namely V634F, V634Y, and V634W), we suspected that 
the ring–ring interaction may contribute to the higher 
apparent ATP affinity in these mutants. If the adenine 
of ATP indeed directly interacts with the side chain of 
residue at position 634, we expect that a mutant cycle 
analysis should reveal that the free energy perturbations 
caused by mutating residue 634 and by altering the base 
of the nucleotide should couple energetically.
However, the estimate of the apparent affinity of ATP 
inhibition based on the change of V1/2 could be prob-
lematic because V1/2 may not truly reflect the change 
of ligand occupancy. For this reason, we model the ATP 
inhibitory  effect  using  a  four-state  allosteric  scheme 
TA B L e   I I
K1/2 and V1/2,max for the ATP dose–response curves of V634 mutants
Channels/mutants K1/2 V1/2, max n
mM mV
WT CLC-1 0.78 ± 0.08 76.9 ± 7.4 8
V634F 0.026 ± 0.002 61.6 ± 4.9 7
V634Y 0.050 ± 0.004 46.6 ± 3.3 5
V634W 0.11 ± 0.01 90.7 ± 9.4 4
V634C 0.81 ± 0.06 70.8 ± 3.3 5
V634S 1.8 ± 0.3 72.9 ± 8.5 4
V634D 7.4 ± 1.5 18.5 ± 3.1 4
V634G 13.3 ± 4.0 77.8 ± 8.1 4
E865D 0.40 ± 0.09 14.2 ± 2.4 6
V613A 2.3 ± 0.3 26.3 ± 3.4 4
E865D-V634F 0.089 ± 0.05 8.7 ± 2.4 4
V613A-V634F 2.3 ± 0.35 62.6 ± 5.4 7
K1/2 determined from Eq. 1, using V1/2 as the response to ATP inhibition. 
Means ± SEM are given.
TA B L e   I I I
Apparent affinities of ATP, CTP, GTP, and dATP for WT CLC-1 and V634F
Channels/mutants Ko or Kc
ATP CTP GTP dATP
mM mM mM mM
Kc
WT CLC-1 0.32 ± 0.04 (8) 1.1. ± 0.2 (6)  9.9 ± 1.0 (5) 0.85 ± 0.14 (4)
V634F 0.017 ± 0.005 (7)  3.5 ± 0.4 (8) 4.0 ± 0.6 (6) 0.049 ± 0.013 (6)
Ω = 60 Ω = 7.6 Ω = 1.09
Ko
WT CLC-1 0.70 ± 0.10 (8) 1.3. ± 0.3 (6)  15.1 ± 1.9 (5)  1.3 ± 0.2 (4)
V634F 0.039 ± 0.013 (7)  8.2 ± 1.2 (8) 8.5 ± 1.6 (6) 0.071 ± 0.021 (6)
Ω = 113 Ω = 10 Ω = 0.98
Calculated from the values of Po
c at 40 mV. Means ± SEM are given. The numbers inside parentheses indicate the number of patches.364 ATP binding to the CLC-1 channel
an action potential (Jentsch et al., 2005). In addition, 
recent studies suggested that the reduction of the Cl 
conductance of the sarcolemma by a low intracellular 
pH (pHi) can help overcome muscle fatigue (Pedersen 
et al., 2004, 2005). Experiments performed several de-
cades ago showed that acidification of muscle cells can 
reduce the muscle Cl conductance (Hutter and Warner, 
1967a,b). However, various experiments on the cloned 
CLC-1 channel showed that reducing pHi increases the 
open probability of CLC-1 (Rychkov et al., 1996; Saviane 
et al., 1999; Accardi and Pusch, 2000). On the other 
hand, we and others recently found that if ATP is in-
cluded in the intracellular solution, reducing pHi de-
creases the CLC-1 activity (Bennetts et al., 2007; Tseng 
et al., 2007). Thus, binding of ATP to the intracellular 
side of CLC-1 appears to be a prerequisite for reducing 
the CLC-1 conductance by a low pHi.
The primary sequences of CLC channels/transporters 
have suggested the presence of a potential ATP-binding 
Although the value of Ω for the former pair of muta-
tions appears to be large, whereas that of the latter pair 
of mutations is smaller (see Fig. S2 B for Ω values at dif-
ferent voltages), the results in both cases suggest that 
the mutational effects of V634F and those of V613A and 
E865D on the ATP regulation may couple together, a 
result consistent with the idea that these residues inter-
act with ATP simultaneously.
D I S C U S S I O N
CLC-1 Cl
 channels contribute a major conductance to 
the  sarcolemmal  membrane  of  skeletal  muscles  and, 
thus, are critical for the membrane excitability of skele-
tal muscles. The importance of CLC-1 in maintaining 
normal muscle functions can be seen from the myoto-
nia disease resulting from defects of CLC-1 (Koch et al., 
1992). Likely, the CLC-1 conductance facilitates repo-
larization of the membrane of skeletal muscles after firing 
Figure 6.  Interaction of nucleotides with residue V634 in the ATP-binding site explored by double mutant cycle analyses. (A) Mutant 
cycle analysis of the interaction of the nucleotide with residue V634. The ATP and CTP dose–response curves of WT CLC-1 and the 
V634F mutant were first constructed using the parameter Po
c(ATP)/Po
c(control) as the dependent parameter. The values of Ko and Kc 
(Table III) of ATP/CTP modulations were determined by fitting the data points to Eq. 2, and the Kc values were used to calculate the 
free energy differences of single or double manipulations (bar graph) according to Eq. 3 and the coupling constant, Ω, according to 
Eq. 4. n = 6–8. (B) Mutant cycle analysis of the nucleotide interaction with V634 using ATP and dATP. The ligand dose–response curves 
of WT CLC-1 and V634F were constructed using Po
c(ATP)/Po
c(control) as the dependent parameter. Ko and Kc were determined (Table III), 
and the Ω value and the free energy differences were calculated accordingly. n = 4–8.  Tseng et al. 365
binding  to  CLC-1  has  still  been  lacking.  With  the 
studies outlined here, we have directly examined the 
interaction of ATP with the amino acid residues lining 
the potential ATP-binding pocket in the CBS domains 
of CLC-1.
To identify the potential residues in CLC-1 that may 
interact with the ATP molecule, we constructed homol-
ogy models of CLC-1 based on the C-terminal structures 
of CLC-5 and CmCLC. Previously, two homology mod-
els have been reported for the C-terminal domain of 
CLC-1. One of them (Bennetts et al., 2005) was con-
structed based on the crystal structure of inosine-mono-
phosphate dehydrogenase (Zhang et al., 1999), which is 
not very reliable because of the low sequence identity 
between CLC-1 and inosine-monophosphate dehydro-
genase (Bennetts et al., 2007). The other model rebuilt 
by Bennetts et al. (2007) was based on the crystal struc-
ture of the C-terminal domain of CLC-0 (Protein Data 
Bank accession no. 2D4Z), which is an apo structure 
with no bound ATP molecule. The alignment between 
site in the CBS domain located at the C terminus of 
CLC molecules. Structural and biochemical experiments 
on the C-terminal domain of CLC-5 demonstrated that 
ATP indeed binds to the predicted CBS domain of CLC-5 
(Meyer et al., 2007). Does ATP also bind to the CBS 
domain of CLC-1 and cause the inhibition of the CLC-1 
current? Recent studies from different laboratories pro-
vided somewhat inconsistent results. Our results (Tseng 
et al., 2007) and those from Bennetts et al. (2007) 
showed that ATP may modulate the common gating of 
CLC-1. On the other hand, Zifarelli and Pusch (2008) 
failed to show an ATP effect on CLC-1 and thus sug-
gested  that  the  ATP  modulation  of  CLC-1  may  be 
achieved via an accessory protein. Although our further 
experiments showed that the ATP regulation of CLC-1 
is modulated by oxidation and reduction (Zhang et al., 
2008) and thus suggested that the variation of the oxida-
tion reduction level in various experimental conditions 
could be one of the underlying reasons for inconsistent 
experimental  findings,  the  evidence  of  a  direct  ATP 
Figure 7.  Nonadditive effects of mutations on the ATP modulations of CLC-1. The parameter Po
c(ATP)/Po
c(control) was used as the 
response to ATP modulation. (A) Mutant cycle analysis of the effects of V634F and V613A mutations on the ATP modulation. ATP 
dose–response curves of single point mutants and the double mutants were constructed to determine the values of Ko and Kc. The fitted 
Kc values were used to calculate the free energy differences of single or double mutants (bar graph) according to Eq. 3 and the coupling 
constant, Ω, according to Eq. 4. In the context of Eq. 2, the V634F mutation corresponds to the change from X1 to X2, whereas the V613A 
mutation represents the change from Y1 to Y2. (B) Double mutant cycle analysis for V634F/E865D mutations. The values of Ω at different 
voltages are shown in Fig. S2. Error bars represent SEM. n = 4–8.366 ATP binding to the CLC-1 channel
crucial for the ATP modulation. Because placing aro-
matic amino acids at position 634 increased the appar-
ent ATP affinity, we hypothesized that the aromatic ring 
of these amino acids may directly interact with the ade-
nine of ATP. To further explore this possibility, we stud-
ied the apparent affinities of various nucleotides on 
WT CLC-1 and on the V634F mutant and showed that the 
Ω values from mutant cycle analyses are significantly de-
viated  from  unity  for  ATP/CTP  and  ATP/GTP  pairs 
(Fig. 6 A and Table III). However, using ligands that dif-
fer in the ribose moiety (dATP vs. ATP) as the modula-
tion ligands showed that the Ω value is close to unity 
(Fig. 6 B and Table III). These results are consistent with 
the hypothesis that the base moiety of the bound nucle-
otide in the CBS domain of CLC-1 interacts directly with 
residue V634.
Thus, the amino acid residue of V634 in CLC-1, like 
the corresponding residue in CLC-5 (Y617), should be 
critical for ATP binding to the CBS domain. In addition 
to V634, three other amino acid residues shown in this 
study also affect the ATP modulation of CLC-1. We won-
dered whether the mutations at these various positions 
affect the ATP binding independently. If so, the free en-
ergy change generated by the double mutation is ex-
pected to be a summation of the free energy changes 
from individual mutations. For this purpose, we used 
mutant cycle analyses to examine the interaction between 
the mutation V634F and two other mutations, V613A 
and E865D. We chose these two latter mutations be-
cause the mutants still retain some ATP inhibitions for 
constructing a reliable ATP dose-dependent curve. The 
apparent K1/2 of the ATP modulations for the single 
point mutants and the double mutants are shown in 
Table II. Fig. 7 A shows the double mutant cycle analysis 
for V613A and V634F mutations. The results show a 
violation of the independency of the two mutations be-
cause the Ω value from this mutant cycle analysis clearly 
deviates  from  unity,  indicating  that  the  free  energy 
change of the double mutant V613A/V634F (compared 
with the WT channel) is not the sum of the free energy 
changes from the V613A and V634F mutations. In com-
parison, experiments with V634F and E865D mutants 
appear to have a smaller Ω value of only 6.7 (Fig. 7 B). 
We have no definitive interpretation of the large cou-
pling energy between V613A and V634F mutations and 
the small coupling energy between V634F and E865D 
except speculating that V613 and V634 interact with the 
adenine ring of ATP, whereas V634 and E865 may be 
separated in farther distance. Nonetheless, the nonad-
ditive effects of individual mutations and the strong en-
ergetic coupling in ATP/CTP and ATP/GTP bindings 
provide evidence against the idea that the ATP modula-
tion on CLC-1 is mediated by an accessory protein.
Previous studies by others and our own experiments 
showed that the inhibition of the CLC-1 common gat-
ing by ATP can also be achieved by ADP and AMP 
the C-terminal structures of CLC-0 and CLC-5 shows a 
somewhat different orientation of the two CBS domains 
(Meyer et al., 2007). Similarly, the two CLC-1 C-terminal 
models we built based on CLC-5 and CmCLC structures 
also show quite a significant difference in the relative 
positions of the two CBS domains (and thus the resi-
dues interacting with ATP; Fig. S1). It cannot be excluded 
at this moment that part of the difference among vari-
ous C-terminal structures results from an ATP-induced 
conformational change. Because the structure of the 
CLC-5’s  C-terminal  domain  contains  ATP,  we  used 
the homology model based on this structure to guide 
our experiments.
Although CLC-1 and CLC-5 only show 20% sequence 
identity, the homology model of the potential ATP- 
binding site in CLC-1 is quite similar to that in the   
C-terminal structure of CLC-5. For example, the resi-
dues V634 and E865 that correspond to Y617 and D727 
of CLC-5 in sequence alignment are also located in the 
ATP-binding sites, and their side chains appear to inter-
act with the adenine ring and the ribose of the bound 
ATP, respectively (Fig. 1), just like in the structure of the 
CLC-5  C-terminal  domain.  Mutating  both  V634  and 
E865 into alanine eliminates the ATP effect, a result 
consistent with biochemical data from CLC-5. In addi-
tion, the homology model also suggests that two other 
residues, V613 and V860, may also interact with ATP. 
Mutating these four residues in the potential ATP-
binding  pocket  resulted  in  various  consequences.   
Overall, the mutations at the V634 position are relatively 
tolerable for the functional expression of the channel. 
All mutations here resulted in functional mutant chan-
nels. For the mutations at positions V613, V860, and 
E865, four out of seven mutations at each position did 
not produce functional current. We have not character-
ized whether the mutations at these three positions 
resulted in nonfunctional channels or whether the mu-
tations simply caused a problem of membrane traffick-
ing.  For  those  mutants  that  can  generate  functional 
current, the ATP regulation of CLC-1 was altered.
Overall, the majority of the mutants cause a suppres-
sion of the ATP effect; either the apparent affinity (K1/2) 
or the efficacy (the maximal V1/2) of the ATP modula-
tion is reduced, or both. However, introducing an aro-
matic residue at position 634 generates mutant channels 
with a higher apparent ATP affinity. It is worth pointing 
out that WT CLC-1 contains a valine residue at position 
634, whereas the corresponding residue in CLC-5 is 
tyrosine. The apparent K1/2 of the ATP in WT CLC-1 at 
pHi 6.8 is higher than that in CLC-5 (90 µM) observed 
by  Meyer  et  al.  (2007)  based  on  a  binding  assay,  al-
though a patch-clamp study by Zifarelli and Pusch (2009) 
reported that the ATP affinities of CLC-5 are 0.43 mM 
and 0.89 mM for the active and inactive states of this 
transporter, respectively. Nonetheless, both studies showed 
that  the  corresponding  residue  (Y617)  in  CLC-5  is   Tseng et al. 367
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(Bennetts et al., 2005; Zhang et al., 2008). It was shown 
that there is no discrimination in binding ATP, ADP, 
and AMP to the CBS domains of CLC-5 (Meyer et al., 
2007). This similarity seems to argue for a similar overall 
architecture of the two binding sites, although the   
sequence  homology  of  the  CBS  domains  of  CLC-1 
and CLC-5 is quite low (30%). However, binding of   
nucleotides/nucleosides to CLC-5 potentiates but does 
not inhibit the transport activity of CLC-5 (Zifarelli and 
Pusch, 2009). In AtCLC-a, however, it was found that 
ATP has an inhibitory effect, whereas ADP and AMP do 
not have any direct effect except that AMP is able to 
compete with ATP for binding (De Angeli et al., 2009). 
The molecular basis underlying these detailed functional 
variations among the nucleotide/nucleoside effects of 
these three CLC molecules remains unclear. One possible 
explanation is that binding of nucleotides/nucleosides to 
the CBS domain may induce different allosteric effects 
in different CLC molecules. Thus, the ATP modulation 
mechanisms could be quite different in various CLC 
molecules (Zifarelli and Pusch, 2009).
In summary, the experiments presented in this study 
have identified several amino acid residues that may di-
rectly interact with the bound ATP molecule in the CBS 
domain of CLC-1. The results thus argue that ATP mod-
ulates the common gating of CLC-1 via a direct binding 
to  the  C-terminal  domain  of  CLC-1.  Given  the  large 
shift of the Po
c-V curve, modulation of the CLC-1 com-
mon gating should be a useful model to study ATP inter-
action with the CBS domain. It will also be interesting to 
examine  the  functional  roles  of  the  corresponding 
residues in other CBS domain–containing molecules.   
Such a comparison of the effects of the corresponding 
mutations in different molecules could provide a deeper 
understanding  of  the  molecular  interaction  between 
nucleotide and the CBS domain.
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